Correspondence 0001213900-25-011284 from OS Therapies Inc (OSTX)
OS Therapies Inc
Date: Feb. 7, 2025 · CIK: 0001795091 · Accession: 0001213900-25-011284
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284631
Letter
EMAIL: SFeldman@olshanlaw.com
DIRECT DIAL: 212.451.2234
February 7, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Tim Buchmiller
Office of Life Sciences
Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-284631)
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated, a Delaware corporation (the “Company”), we enclose the Company’s request for acceleration of the above-referenced Registration Statement to 4:30 p.m., Eastern time, on Thursday, February 13, 2025, or as soon as practicable thereafter.
Please advise the undersigned of the effectiveness of the Registration Statement.
Very truly yours,
/s/ Spencer G. Feldman
Spencer G. Feldman
cc: Paul A. Romness, MPH
February 7, 2025
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.: Tim Buchmiller
Office of Life Sciences
Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-284631)
Ladies and Gentlemen:
OS Therapies Incorporated hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:30 p.m., Eastern time, on Thursday, February 13, 2025, or as soon as practicable thereafter.
Very truly yours,
OS Therapies Incorporated
Show Raw Text
CORRESP
1
filename1.htm
EMAIL: SFeldman@olshanlaw.com
DIRECT DIAL: 212.451.2234
February 7, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.:
Tim Buchmiller
Office of Life Sciences
Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-284631)
Ladies and Gentlemen:
On behalf of OS Therapies
Incorporated, a Delaware corporation (the “Company”), we enclose the Company’s request for acceleration of the above-referenced
Registration Statement to 4:30 p.m., Eastern time, on Thursday, February 13, 2025, or as soon as practicable thereafter.
Please advise the undersigned
of the effectiveness of the Registration Statement.
Very truly yours,
/s/ Spencer G. Feldman
Spencer G. Feldman
cc: Paul A. Romness, MPH
February
7, 2025
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn.:
Tim Buchmiller
Office of Life Sciences
Re: OS Therapies Incorporated
Registration Statement on Form S-1 (No. 333-284631)
Ladies and Gentlemen:
OS Therapies Incorporated
hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective
at 4:30 p.m., Eastern time, on Thursday, February 13, 2025, or as soon as practicable thereafter.
Very truly yours,
OS Therapies Incorporated
By:
/s/ Paul A. Romness
Paul A. Romness
President and Chief Executive Officer